Solid Biosciences (SLDB) PT Raised to $18 at Piper Sandler
Tweet
Share
E-mailGet Alerts SLDB Hot Sheet
Price: $8.30 -0.36%
Rating Summary:
16 Buy, 3 Hold, 1 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 18 | Down: 12 | New: 24
Rating Summary:
16 Buy, 3 Hold, 1 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 18 | Down: 12 | New: 24
Join SI Premium – FREE
Piper Sandler analyst Biren Amin raised the price target on Solid Biosciences (NASDAQ: SLDB) to $18.00 (from $17.00) while maintaining a Overweight rating.
You May Also Be Interested In
- Umicore SA (UMI:BB) (UMICY) PT Raised to EUR27 at JPMorgan
- Elisa Oyj (ELISA:FH) (ELMUF) PT Lowered to EUR40 at Barclays
- Incyte (INCY) PT Raised to $105 at Truist Securities
Create E-mail Alert Related Categories
Analyst PT ChangeSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
